Auto saved by Logseq

master
FMS 1 year ago
parent 2b09f0fba3
commit 1c9eb4f42b

@ -60,7 +60,8 @@
- El clinical trial is under review. Nothing to highlight regarding safety, which lead us to go to test safety with bigger populations.
- consideramos lo de 3 dosis para situaciones que no son las de MDA sino otros escenarios.
- For strongi we didn't reach the recruitement size. The answer we wanted to provide we couldnt give.
-
- Our project is proposing an innovation with our fdc but also for other ways of getting ivm.
- Safety, palatability and
-
- ## Cosas de gastos del [[Evento]]
- Sala, catering, técnicos (Caixaforum)

Loading…
Cancel
Save